发明名称 IL-8 RECEPTOR ANTAGONISTS
摘要 This invention relates to novel spiro containing compounds of Formula (I), and compositions thereof, useful in the treatment of diesease states mediated by the chemokine, Interleukin-8 (IL-8). Compounds of Formula (I) are represented, interalia, by structure (I) wherein, R is -NH -C(X)-NH- (CR13R14)v-Z; Z is optionally substituted phenyl or naphtyl, optionally substituted heteroaryl, optionally substituted C5-8 cycloalkyl, optionally substituted C1-10 alkyl, optionally substituted C2-10 alkenyl, or an optionally substituted C2-10 alkynyl; X is =O, or =S; A is carbon which is contained within a 3-7 membered spiro ring, which ring may optionally contain a heteroatom selected from O/N/S; v is 0, or an integer having a value of 1 to 4; or a pharmaceutically acceptable salt thereof.
申请公布号 WO9911253(A1) 申请公布日期 1999.03.11
申请号 WO1998US18563 申请日期 1998.09.04
申请人 SMITHKLINE BEECHAM CORPORATION;NIE, HONG;WIDDOWSON, KATHERINE, L. 发明人 NIE, HONG;WIDDOWSON, KATHERINE, L.
分类号 A61K31/335;A61K31/35;A61K31/38;A61K31/405;A61K31/41;A61K31/42;A61K31/425;A61K31/428;A61K31/435;A61K31/44;A61K31/445;A61K31/495;A61K31/50;A61K31/505;A61K31/517;A61K31/52;A61K31/535;A61P1/00;A61P7/00;A61P7/02;A61P7/08;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/02;A61P19/08;A61P25/28;A61P31/04;A61P37/00;A61P37/06;A61P39/00;A61P39/02;A61P43/00;C07D233/54;C07D233/60;C07D239/26;C07D239/70;C07D239/74;C07D241/12;C07D241/36;C07D275/06;C07D487/10;(IPC1-7):A61K31/17;A61K31/34;A61K31/40;A61K31/415;A61K31/47;C07C273/02;C07C273/18;C07C275/30;C07C275/50;C07C275/52;C07C275/54;C07D207/12;C07D207/14;C07D209/08;C07D209/18;C07D209/96;C07D211/82;C07D215/12;C07D215/36;C07D215/38;C07D217/02;C07D217/12;C07D231/00;C07D231/06;C07D231/44;C07D231/54;C07D235/28;C07D235/30;C07D261/08;C07D261/20;C07D263/32;C07D263/52;C07D265/30;C07D265/34;C07D285/04;C07D285/14;C07D307/36;C07D307/94;C07D309/34;C07D311/96;C07D333/10;C07D333/50;C07D417/04;C07D417/10;C07D455/02;C07D513/10 主分类号 A61K31/335
代理机构 代理人
主权项
地址